Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

Delayed Data
As of May 27
 -0.35 / -0.59%
Today’s Change
Today|||52-Week Range
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pip...
2:18pm / MotleyFool.com - Paid Partner Content
Lilly's (LLY) R&D Update, Targets 20 New Launches by 2023
May 25 / Zacks.com - Paid Partner Content
Shares Of Relypsa Inc. Are Surging Again -- Here's Why
May 27 / MotleyFool.com - Paid Partner Content
Why Relypsa Inc. Is Moving Higher Today
May 23 / MotleyFool.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Here's What Pfizer's Telling Us About Biotech M&A
May 21 / MotleyFool.com - Paid Partner Content
Bret Jensen Reporting for Duty
May 27 / TheStreet.com - Paid Partner Content
AstraZeneca's Severe Asthma Drug Positive in Phase III
May 18 / Zacks.com - Paid Partner Content
Relypsa Scores Big Win When Pharma Rival Flops at FDA
May 27 / TheStreet.com - Paid Partner Content
Stocks: 5 things to know before the open
Apr 29 / CNNMoney.com

Today’s Trading

Previous close59.20
Today’s open58.85
Day’s range58.85 - 58.85
Average volume (3 months)1,206
Market cap$74.4B
Dividend yield5.05%
Data as of 12:19pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+127.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-5.32%
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London


Partner Offers

Search for Jobs